These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 568069)

  • 1. The central effects of a novel dopamine agonist.
    Setler PE; Sarau HM; Zirkle CL; Saunders HL
    Eur J Pharmacol; 1978 Aug; 50(4):419-30. PubMed ID: 568069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro.
    Arnt J; Hyttel J; Sánchez C
    Eur J Pharmacol; 1992 Mar; 213(2):259-67. PubMed ID: 1355737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity.
    Mishra RK; Gardner EL; Katzman R; Makman MH
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):3883-7. PubMed ID: 4372596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinhibitory effects of SK&F 85174, a novel dopamine receptor agonist.
    Blumberg AL; Wilson JW; Hieble JP
    J Cardiovasc Pharmacol; 1985; 7(4):723-32. PubMed ID: 2410714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
    Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines.
    Ginos JZ; Cotzias GC; Tolosa E; Tang LC; LoMonte A
    J Med Chem; 1975 Dec; 18(12):1194-1200. PubMed ID: 1238569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evidence for the subclassification of central dopamine receptors in the rat.
    Gower AJ; Marriott AS
    Br J Pharmacol; 1982 Sep; 77(1):185-93. PubMed ID: 6889902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor 'supersensitivity' occurring without receptor up-regulation.
    Mileson BE; Lewis MH; Mailman RB
    Brain Res; 1991 Oct; 561(1):1-10. PubMed ID: 1686741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the acoustic startle response by dopamine agonists after 6-hydroxydopamine lesions of the substantia nigra pars compacta: corresponding changes in c-Fos expression in the caudate-putamen.
    Meloni EG; Davis M
    Brain Res; 2000 Oct; 879(1-2):93-104. PubMed ID: 11011010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Biochem Pharmacol; 1995 May; 49(9):1185-93. PubMed ID: 7763300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG; Kobierski LA; Konradi C; Hyman SE
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.
    Mottola DM; Kilts JD; Lewis MM; Connery HS; Walker QD; Jones SR; Booth RG; Hyslop DK; Piercey M; Wightman RM; Lawler CP; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1166-78. PubMed ID: 12023552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of electrolytic and 6-hydroxydopamine lesions of the lateral hypothalamus on rotation evoked by electrical stimulation of the substantia nigra in rats.
    Saranak J; Goldfarb J
    Brain Res; 1981 Mar; 208(1):81-95. PubMed ID: 7193503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites.
    Kebabian JW; Saavedra JM
    Science; 1976 Aug; 193(4254):683-5. PubMed ID: 181842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model.
    Carey RJ
    Brain Res; 1990 May; 515(1-2):292-8. PubMed ID: 2113414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists.
    Mavridis M; Colpaert FC; Millan MJ
    Brain Res; 1991 Oct; 562(2):216-24. PubMed ID: 1685341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.
    Sañudo-Peña MC; Force M; Tsou K; Miller AS; Walker JM
    Synapse; 1998 Oct; 30(2):221-6. PubMed ID: 9723792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.